Shenyang Xingqi Pharmaceutical Co.,Ltd
SZSE:300573.SZ
150.38 (CNY) • At close October 26, 2023
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||
| Nettowinst
| 240.036 | 211.684 | 209.108 | 93.46 | 29.511 | 9.008 | 38.438 | 54.279 | 21.98 | 31.01 | 46.097 | 43.703 | 35.637 |
| Afschrijvingen & Amortisatie
| 91.061 | 74.375 | 67.285 | 45.507 | 40.557 | 35.844 | 37.246 | 38.033 | 37.612 | 32.864 | 10.875 | 4.148 | 0 |
| Uitgestelde Inkomstenbelasting
| 0.736 | -5.62 | -2.591 | -0.469 | -7.55 | -0.215 | 0.032 | -2.601 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 23.42 | 39.955 | 13.313 | 4.188 | 8.915 | 1.486 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -53.266 | -53.967 | 9.451 | -34.305 | -17.201 | -11.079 | -47.992 | -64.306 | -51.312 | -49.902 | -49.473 | 0 | 0 |
| Vorderingen
| -104.383 | -37.513 | -33.43 | -61.272 | -47.048 | -19.339 | -26.642 | -60.387 | -51.433 | -48.126 | -52.123 | 0 | 0 |
| Voorraden
| -22.049 | -34.345 | -27.803 | 8.714 | -25.68 | -3.625 | -8.059 | -10.342 | -0.992 | -18.722 | -10.45 | 0 | 0 |
| Crediteuren
| 73.166 | 23.511 | 73.274 | 18.723 | 63.077 | 12.101 | -13.323 | 9.024 | 0 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 23.42 | -5.62 | -2.591 | -0.469 | -7.55 | -7.453 | -39.933 | -53.964 | -50.32 | -31.18 | -39.022 | 0 | 0 |
| Overige Niet-Contante Posten
| 15.581 | 48.785 | 10.39 | 13.778 | 19.849 | 10.235 | 5.006 | 0.116 | 13.153 | -0.974 | 0.899 | -43.703 | -35.637 |
| Kasstroom uit Operationele Activiteiten
| 317.568 | 286.264 | 306.956 | 122.158 | 74.081 | 44.009 | 32.697 | 28.122 | 21.433 | 12.998 | 8.398 | 41.962 | 24.539 |
| Investeringsactiviteiten: | |||||||||||||
| Investeringen in Materiële Vaste Activa
| -261.963 | -299.227 | -95.055 | -108.152 | -69.976 | -45.287 | -29.29 | -3.62 | -4.687 | -81.792 | -132.98 | -103.253 | -42.056 |
| Netto Overnames
| 0.021 | 0.077 | 1.257 | 0.005 | 1.931 | 10.899 | 4.105 | 7.834 | 13.747 | -1.747 | 0 | 0 | 0.116 |
| Aankoop van Beleggingen
| 0 | 0 | -130.476 | 0 | 0 | 0 | -2.195 | 0 | -3.401 | 15.7 | 0 | 0 | -0.675 |
| Verkoop/verval van Beleggingen
| 0 | 0 | 0.237 | 0 | 0 | 0 | 0 | 3.54 | 0.138 | 0.05 | 0 | 0.15 | 2.77 |
| Overige Investeringsactiviteiten
| 0 | 0 | 22.027 | -108.152 | -1.9 | 0.199 | 0.105 | 8.225 | 11.3 | 4.96 | 12.773 | 4.851 | -0.002 |
| Kasstroom uit Investeringsactiviteiten
| -261.942 | -299.15 | -202.01 | -108.147 | -69.944 | -45.088 | -31.38 | 8.144 | 17.097 | -62.829 | -120.207 | -98.252 | -39.847 |
| Financieringsactiviteiten: | |||||||||||||
| Schuldaflossingen
| -70 | -120 | -80 | -130 | -103 | -80 | -108 | -120 | -167 | -220.7 | -65.7 | 0 | -15.147 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0.272 | 0.536 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | -0.272 | -0.536 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -177.11 | -79.284 | -41.175 | -10.304 | -20 | -22.878 | -13.009 | -6.557 | -10.595 | -10.534 | -3.671 | 0 | -23.533 |
| Overige Financieringsactiviteiten
| 30.614 | 42.418 | 665.25 | 131.119 | 133.244 | 110.108 | 51.33 | 170.05 | 129.3 | 276.416 | 51.828 | 48.726 | 105.891 |
| Kasstroom uit Financieringsactiviteiten
| -84.168 | -158.424 | 538.121 | -15.077 | 5.788 | 7.23 | -69.678 | 43.493 | -48.295 | 45.182 | 48.158 | 48.726 | 67.211 |
| Overige Informatie: | |||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.2 | -0.09 | -0.125 | -0.023 | 0.011 | -0.066 | 0.036 | 0.02 | -0.299 | -0.061 | 0.063 | 0.202 | -0.881 |
| Netto Kasstroomverandering
| -35.032 | -171.401 | 642.941 | -1.088 | 9.936 | 6.085 | -68.326 | 79.78 | -10.064 | -4.709 | -63.589 | -7.362 | 51.022 |
| Kaspositie aan het Einde van de Periode
| 480.418 | 508.76 | 680.16 | 37.219 | 38.307 | 28.371 | 22.286 | 90.612 | 10.831 | 20.896 | 25.605 | 89.193 | 96.555 |